Company Information
Member Since 5 Years
Nature of Business Supplier Year of Establishment 2009Ask for more detail from the seller
Contact Supplier
LGD-4033 works by tying androgen receptors selectively. It shows anabolic activity in the bones and muscles instead of harmfully affecting the prostate and sebaceous glands which usually happens when using steroids. LGD-4033 just concluded a study called Phase I Multiple Ascending Dose which included fit volunteers. This was an unplanned, double bind analysis stage that included a placebo. The objective was to form that using LGD-4033 was harmless and easy to stomach with a dose not beyond 22 mg a day.
Connect with us
For Buyer 
For Seller 
Help 
Amsterdam 
Send Enquiry